col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


30 Results       Page 1

 [1] 
Elsevier: Phytomedicine Plus
  original article Date Title Authors   All Authors
1 [GO] 2026―Mar―07 Integrated docking, ADMET, and molecular dynamics study of red betel (Piper crocatum) compounds against SARS-CoV-2 targets Dikdik Kurnia, Sefren Geiner Tumilaar, Devi Meliani, Dudi Dudi, Diding Latipudin
2 [GO] 2026―Jan―07 Oro-nasal film spray with andrographolide blocks SARS-CoV-2 and influenza infections and strengthens mucosal innate immunity Wipawee Nittayananta, Nopporn Chutiwitoonchai, Hatairat Lerdsamran, Aornrutai Promsong, Teerapol Srichana, Kesinee Netsomboon, et al. (+2)
3 [GO] 2025―Nov―19 Immunomodulatory and antiviral properties of herbal formulation: Evidence from clinical trials in healthy volunteers, COVID-19 patients and molecular docking studies Sarvesh Kumar Singh, Kshipra Rajoria, Sanjeev Sharma, Sudhir Dadram Patsute, Suchitra Ganeshacharya, Sarita Singh, et al. (+3)
4 [GO] 2025―Sep―23 Oroxylum indicum and flavonoids impact on SARS-CoV-2 and urban dust-induced inflammation in human lung fibroblast cells Khunkhang Butdapheng, Rattanathorn Choonong, Waranyoo Phoolcharoen, Waraporn Putaluna
5 [GO] 2025―Aug―11 “Status of Evidence on Efficacy and Safety of Indian Traditional Medicine (AYUSH) for COVID-19: Protocol for a Country-specific Qualitative Review and Evidence Map Synthesis” Azeem Ahmad, Manohar S. Gundeti, Meena R, Eugene Wilson, Malik Itrat, Ghazala Javed, et al. (+10)
6 [GO] 2025―Jul―28 Andrographis paniculata or Favipiravir in Mild COVID-19: A Randomized Control Trial Rujipas Sirijatuphat, Navin Horthongkham, Chutikarn Chaimayo, Patimaporn Wongprompitak, Wuttikrai Kongsankum, Phornnapa Charoenkij, et al. (+7)
7 [GO] 2025―Jul―26 Potential of diterpenoid andrographolide in COVID-19 therapy: an insight on its antiviral-, immunomodulatory-, anti-inflammatory-, antioxidant- and antithrombotic- properties Biswanath Dinda, Manikarna Dinda, Subhajit Dinda, Bishu Karmakar
8 [GO] 2025―Jul―25 Comprehensive insights into the therapeutic effects of baicalein and baicalin against SARS-COV-2 infection Cheng-Han Lin, Meng-Wei Lin, Hua-Hsin Chiang, Ting-Hsuan Wu, Chin-Hung Tsai, Chih-Sheng Lin
9 [GO] 2024―Dec―03 Exploring the antimicrobial and antioxidative potential of Leucas aspera (Willd.) Link: Phytochemical screening, molecular docking, and HR-LC/MS profiling against SARS-CoV-2 protein 3CLPro, Spike and RDB T.S Shalini, Prathiviraj Ragothaman, P Senthilraja
10 [GO] 2024―Dec―02 Coronil effectively inhibits the interaction of clinically relevant Omicron mutants of SARS-CoV-2 Spike Proteins with human ACE2 receptor Acharya Balkrishna, Rishabh Dev, Sandeep Kumar, Anurag Varshney
11 [GO] 2024―Apr―16 In vitro study on the inhibitory effect of various essential oils against murine coronavirus mouse hepatitis virus A-59 replication Karelle Contant, Shiv Shankar, Monique Lacroix
12 [GO] 2024―Feb―03 Potential benefits and challenges on the use of phytochemicals for obese COVID-19 patients: A review Murtala Bello Abubakar, Abdurrahman Pharmacy Yusuf, Dawoud Usman, Ibrahim Babangida Abubakar, Babangida Sanusi Katsayal, Idris Zubairu Sadiq, et al. (+5)
13 [GO] 2023―Nov―18 Review on the secondary metabolites, biological properties, and ethnomedicinal uses of the component species of the Buheri wa Afya formula used to treat COVID-19 in Tanzania John J. Makangara, Anthony M. Mshandete, Ernest R. Mbega, John R. Nyika, Frank Mbago, Edward G. Ndilanha, et al. (+2)
14 [GO] 2023―Oct―15 Iran's commercial herbal products for managing COVID-19: A review based on clinical trial-based approach Vahideh Ahmadpour, Saba Rahimi Bahoosh, Parvin Jahanbani, Mahdieh Eftekhari
15 [GO] 2023―Mar―11 Effects of diarylbutane lignans from Schisandra chinensis fruit on SARS-CoV-2 3CLpro and PLpro and their in vitro anti-inflammatory properties Bin Li, Liansheng Qiao, Qi Xiao, Jianuo Zhang, Jiushi Liu, Bengang Zhang, Haitao Liu
16 [GO] 2022―Dec―30 Therapeutic potential of green tea catechin, (-)-epigallocatechin-3-O-gallate (EGCG) in SARS-CoV-2 infection: major interactions with host/virus proteases Biswanath Dinda, Subhajit Dinda, Manikarna Dinda
17 [GO] 2022―Dec―20 A randomized controlled pilot study of add-on therapy of CIM-MEG19 (standardized Andrographis paniculata formulation) in mild to moderate COVID-19 Karuna Shanker, Hrishikesh Rangnekar, Asmita Wele, Pravin Soni, Pranesh Gaikwad, Anirban Pal, et al. (+2)
18 [GO] 2022―Apr―20 Ayurvedic formulations: potential COVID-19 therapeutics? Anees Ahmed Mahaboob Ali, Andrea Bugarcic, Nenad Naumovski, Reena Ghildyal
19 [GO] 2022―Apr―18 Herbal medications and natural products for patients with covid-19 and diabetes mellitus: potentials and challenges Abdurrahman Pharmacy Yusuf, Jian-ye Zhang, Jing-quan Li, Aliyu Muhammad, Murtala Bello Abubakar
20 [GO] 2022―Mar―04 Research on the mechanism of berberine in the treatment of COVID-19 pneumonia pulmonary fibrosis using network pharmacology and molecular docking Junfeng Cao, Lianglei Li, Li Xiong, Chaochao Wang, Yijun Chen, Xiao Zhang
21 [GO] 2022―Feb―12 Molecular and structural insights of β-boswellic acid and glycyrrhizic acid as potent SARS-CoV-2 Envelope protein inhibitors Syeda Warisul Fatima, Shahenvaz Alam, Sunil K. Khare
22 [GO] 2022―Feb―08 Effects of theaflavin-gallate in-silico binding with different proteins of SARS-CoV-2 and host inflammation and vasoregulations referring an experimental rat-lung injury. Dr. Smarajit Maiti, Assistant Professor Dr. Amrita Banerjee, Mehak Kanwar
23 [GO] 2021―Sep―29 Computational screening of phytochemicals from three medicinal plants as inhibitors of transmembrane protease serine 2 implicated in SARS-CoV-2 infection Omotayo O. Oyedara, Joseph M. Agbedahunsi, Folasade M. Adeyemi, Alfredo Juárez-Saldivar, Olatomide A. Fadare, Charles O. Adetunji, Gildardo Rivera
24 [GO] 2021―Jul―13 Computational and network pharmacology studies of Phyllanthus emblica to tackle SARS-CoV-2 Rupesh V. Chikhale, Saurabh K. Sinha, Pukar Khanal, Nilambari S. Gurav, Muniappan Ayyanar, Satyendra K. Prasad, et al. (+3)
25 [GO] 2021―Jun―06 Phytoconstituents from ten natural herbs as potent inhibitors of main protease enzyme of SARS-COV-2: in silico study Nitish Kumar, Atamjit Singh, Harmandeep Kaur Gulati, Kavita Bhagat, Komalpreet Kaur, Jaspreet Kaur, et al. (+6)
26 [GO] 2021―Mar―20 The potential of BEN815 as an anti-inflammatory, antiviral and antioxidant agent for the treatment of COVID-19 Jin A. Shin, Subin Oh, Jong-Moon Jeong
27 [GO] 2021―Feb―17 The potential of glycyrrhizin and licorice extract in combating COVID-19 and associated conditions Adel A. Gomaa, Yasmin A. Abdel-Wadood
28 [GO] 2021―Jan―18 Insights into Forsythia Honeysuckle (Lianhuaqingwen) Capsules: A Chinese Herbal Medicine Repurposed for COVID-19 Pandemic Chengyuan Liang, Nan Hui, Yuzhi Liu, Guaiping Qiao, Juan Li, Lei Tian, et al. (+7)
29 [GO] 2020―Dec―31 SARS-CoV-2 spike protein-, main protease- and papain-like-protease-targeting peptides from seed proteins following gastrointestinal digestion: An in silico study Fai-Chu Wong, Joe-Hui Ong, Tsun-Thai Chai
30 [GO] 2020―Nov―27 nnNature's therapy for COVID-19: Targeting the vital Non-Structural Proteins (NSP) from SARS-CoV-2 with phytochemicals from Indian medicinal plants Pratap Kumar Parida, Dipak Paul, Debamitra Chakravorty
 [1] 

30 Results       Page 1


[de][en]

Last change 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.005 sec